Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

telos rx vs Vaylen

By GLP-1 ScorecardUpdated

telos rxFactor scores not reassessed.
Site position #13

Higher score

VaylenFactor scores not reassessed.
Site position #45

Lower score

Score comparison

telos rx has the higher recorded score — 85.4/100 to 77.9/100.

telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telos offers compounded oral and injectable formats; discounted plans can carry early-exit adjustments.

Before you choose

Before comparing the headline prices, the telos rx review and the Vaylen review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, telos rx vs Vea Health and Tyde Wellness vs Vaylen compare each of them with another graded program, and the list of alternatives to telos rx ranks the programs closest to telos rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Gala Health review covers one graded close to these two, at 82.9/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuetelos rx +20
87
67
Dose & formulationtelos rx +2
90
88
Clinical oversightEven
84
84
Labs & monitoringtelos rx +3
80
77
FulfillmentVaylen +3
87
90
Contract termstelos rx +25
80
55
telos rx · top barVaylen · bottom bar

The numbers

Swipe or scroll to compare both providers.

Metrictelos rxVaylen
WeighScore85.4/10077.9/100
GradeBC+
Site position#13#45
SemaglutideAdvertised from $99/month injectable; plan-dependent; selected bill unverified.$99/mo advertised (monthly option; conflicting annual totals)
TirzepatideAdvertised from $139/month injectable; from $116/month microdosed injection; selected bills unverified.From $99/mo (12-month prepaid equivalent; monthly-plan price not confirmed)
CoverageAdvertises all 50 states; pharmacy and formulation availability varies.Public disclosures differ between 49 and 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
telos rx

Site position #13 · B

Factor scores not reassessed.

Strengths

  • Names its care organization and pharmacy partners
  • Oral and injectable compounded options

What to consider

  • Early cancellation can reprice supplied months
  • Entity, denial-refund and lab terms conflict
  • Current oral invoice and renewal price unverified
Vaylen

Site position #45 · C+

Factor scores not reassessed.

Strengths

  • Shows a separate month-to-month semaglutide option
  • Advertises injectable and oral compounded options
  • Describes cancellation through the patient portal for monthly plans

What to consider

  • The annual semaglutide card shows $828 and the FAQ states $996
  • The offer and terms describe different payment timing and clinical groups
  • Confirm coverage, the dispensing pharmacy and any named branded drug with the provider

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard